3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
13
Colorectal Neoplasms
6
Neoplasms
4
Thyroid Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Unmet Fertility Information Needs
1
Thyroid Cancer, Papillary
1
Smoking Cessation
1
Patient Participation
1
Papillary Thyroid Microcarcinoma
1
Neuroma, Acoustic
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Healthy Volunteers
1
Depression
1
Dementia
1
Colorectal Cancer Screening
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
COVID-19
1
Breast Carcinoma In Situ
1
Behavior
1
Advanced Cancer
1
Interventions
Nivolumab
20
Ipilimumab
10
Paclitaxel
7
linrodostat
6
Standard of Care
6
Sirolimus
5
Gemcitabine
5
Bevacizumab
5
temsirolimus
4
relatlimab
4
Pemetrexed
4
Docetaxel
4
Carboplatin
4
ARRY-334543
4
Vorinostat
3
Erlotinib Hydrochloride
3
Dasatinib
3
Cetuximab
3
regorafenib
2
olaparib
2
apatinib
2
anlotinib
2
abemaciclib
2
Trastuzumab
2
Surveys and Questionnaires
2
Sunitinib
2
Sorafenib
2
Olanzapine
2
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Cancer
×
Decision Support Techniques
×
Clear all
NCT04606238
2023-01-10
PETUPAL
University Hospital Heidelberg
Phase NA
Unknown
70 enrolled